# Hypoxia Inducible Factor 1 Alpha as a Novel Biomarker in Septic Shock

> **NCT02163473** · — · COMPLETED · sponsor: **University of Florida** · enrollment: 63 (actual)

## Conditions studied

- Sepsis

## Interventions

- **PROCEDURE:** Septic patients
- **PROCEDURE:** Healthy Control

## Key facts

- **NCT ID:** NCT02163473
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2016-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02163473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02163473, "Hypoxia Inducible Factor 1 Alpha as a Novel Biomarker in Septic Shock". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02163473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*